Bayer

This study is for adults with a heart disease where a protein forms harmful clumps, making it hard for the heart to pump. Researchers want to see if switching patients from their current drug (tafamidis) to a newer one (acoramidis) increases the level of the good protein in their…

This study aims to check if it's safe for people with stable coronary artery disease to use their usual nitroglycerin spray while taking a new investigational drug called nurandociguat. Researchers want to see how these two drugs, which both work to widen blood vessels, interact …

This study is testing whether an investigational drug called BAY 3401016 can slow the loss of kidney function in adults with Alport Syndrome, a rare genetic condition. Researchers will give the drug or a placebo to 60 participants aged 18-45 to see if it reduces protein in the ur…

This study is checking the long-term safety of an experimental drug called finerenone for children with heart failure. It will include up to 117 participants, from newborns to 18-year-olds, who have a weak left heart chamber. All children will receive the drug along with their st…

This study follows 500 men in Germany with advanced prostate cancer that has spread but still responds to hormone therapy. Doctors will track how well the combination of darolutamide (a newer hormone-blocking drug) plus standard hormone therapy works in real-world settings over 5…

This study aims to understand how well a drug called darolutamide works in real-world settings for men with advanced prostate cancer that has spread. It will follow about 1,600 men who are already receiving this drug as part of their standard care, either with or without chemothe…

This study will monitor the safety and real-world use of Octocog alfa, a lab-made clotting factor, in Indian adults with severe Hemophilia A. It will include 33 male patients who have previously received clotting factor treatment and are using Octocog alfa to treat bleeding episo…

This study aims to find the best treatment length before surgery for men with high-risk prostate cancer that hasn't spread. Researchers will compare giving two drugs (darolutamide plus hormone therapy) for either 12 weeks or 24 weeks before prostate removal surgery. The main goal…

This study aims to understand how well a new, non-hormonal medication called elinzanetant works for managing hot flashes, night sweats, and sleep problems in real-world settings. Researchers will follow about 1,500 women in the U.S. who are starting this treatment as part of thei…

This study aims to learn more about how well an already-approved hemophilia A treatment works for children during their regular medical care. Researchers will collect information from about 40 children aged 7 to 12 who are already taking the drug damoctocog alfa pegol to prevent …

This study aims to collect real-world information on how doctors prescribe and use blood-thinning medications (like rivaroxaban) to treat dangerous blood clots in babies and toddlers under 2 years old. Researchers will review the medical records of about 850 children who are alre…

This study aims to understand the risks of taking the Chagas disease medicine nifurtimox during pregnancy. Researchers will follow about 50 women who took the drug while pregnant, collecting data on birth defects, pregnancy outcomes, and the health of their babies for up to a yea…

This study aims to understand how common three serious eye diseases are in Germany and how treatment patterns have changed. Researchers will analyze existing health records from 50,000 people collected between 2009 and 2024. The goal is to map the occurrence of these diseases and…

This study looks back at existing prescription records to understand how Australian men with advanced prostate cancer that has spread are being treated. It focuses on newer hormone-blocking drugs and aims to see which treatments are used, who gets them, and how consistently patie…